Réglementation et droit · 04/12/19951 min de lecture
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Encapsulated High- Concentration Lipid A Composition as Immunogenic Agents
Traduction automatique locale · Langue originale de la source
Résumé
In accordance with 37 CFR 404.6, announcement is made of the availability of U.S. Patent Application Serial No. 07/601,090 filed October 22, 1990 and entitled ``Encapsulated High-Concentration Lipid A Compositions as Immunogenic Agents to Produce Human Antibodies to Prevent or Treat Gram-Negative Bacterial Infections''. This Notice also announces the withdrawal of the intent to grant exclusive patent license to Univax Biologics, Inc. as indicated in the Federal Register, Volume 57, Number 99, page 21648 (May 21, 1992). This patent has been assigned to the United States Government as represented by the Secretary of the Army.